Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Practical and cost-effective model to build and sustain a cardio-oncology program
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Practical and cost-effective model to build and sustain a cardio-oncology program
Creator
Ahmed, Wesam
Alley, Evan
Alvarado, Beatrice
Bastos, Bruno
Chaulagain, Chakra
Cubeddu, Robert
Elson, Leah
Fu, Chieh-Lin
Grossman, David
Nagarajan, Arun
Nahleh, Zeina
Nguyen, Timmy
Sadler, Diego
Samuel, Thomas
Stone, Elizabeth
source
Medline; PMC
abstract
BACKGROUND: Cardio-Oncology (CO) is a new subspecialty that thrives mostly in large academic quaternary centers. This study describes how to establish a successful cardio-oncology program, with limited resources, in order to effectively manage the unique care required by this patient population. METHODS: Clinical data was collected from 25 consecutive months. There were four foundational elements to establish a CO program: 1. Clinical program: integrating staff and resources from the Heart and Vascular, and Cancer Centers; 2. Education Program: establishing a platform to educate/advocate with respect to CO; 3. Engagement with professional societies: active engagement allowed for the successful establishment of the proposed CO program; and 4. Research program: establishing data collection modalities/cooperation with other institutions. RESULTS: 474 consecutive patients were treated by our CO program during the first 25 months of operation. Clinical data, information about cancer treatment, cardiovascular co morbidities, cardiac testing and impact of CO management are reported. CONCLUSIONS: A successful CO program can be established utilizing existing resources without the need for significant additional assets. Integration with professional societies, advocacy, education and research, provide a platform for learning and growth. This model improves access to care and can be reproduced in a variety of settings.
has issue date
2020-07-16
(
xsd:dateTime
)
bibo:doi
10.1186/s40959-020-00063-x
bibo:pmid
32690995
has license
no-cc
sha1sum (hex)
293db2ae54383e782217b4ff809b1d5a19c1ee5e
schema:url
https://doi.org/10.1186/s40959-020-00063-x
resource representing a document's title
Practical and cost-effective model to build and sustain a cardio-oncology program
has PubMed Central identifier
PMC7363993
has PubMed identifier
32690995
schema:publication
Cardiooncology
resource representing a document's body
covid:293db2ae54383e782217b4ff809b1d5a19c1ee5e#body_text
is
schema:about
of
named entity 'Vascular'
named entity 'COLLECTED'
named entity 'Heart'
named entity 'Clinical'
named entity 'Research'
named entity 'Methods'
named entity 'care'
named entity 'Oncology'
named entity 'Cancer Centers'
named entity 'Clinical program'
named entity 'cost-effective'
named entity 'cancer treatments'
named entity 'medical insurance'
named entity 'capecitabine'
named entity 'toxicity'
named entity 'cardiovascular'
named entity 'United States'
named entity 'risk factors'
named entity 'cardiology'
named entity 'echocardiographic'
named entity 'ICOS'
named entity 'oncology'
named entity 'oncology'
named entity 'cancer treatment'
named entity 'clinical development'
named entity 'oncology'
named entity 'cardiovascular health'
named entity 'immunotherapy'
named entity 'nursing staff'
named entity 'biomarkers'
named entity 'myocarditis'
named entity 'heart disease'
named entity 'CMR'
named entity 'COVID 19 pandemic'
named entity 'hematology'
named entity 'multiple myeloma'
named entity 'research projects'
named entity 'cardiac magnetic resonance'
named entity 'registered nurse'
named entity 'coronary artery disease'
named entity 'oncologists'
named entity 'co-morbidities'
named entity 'cardiovascular'
named entity 'oncology'
named entity 'ICOS'
named entity 'cardiologists'
named entity 'beta blockers'
named entity 'proteasome'
named entity 'heart disease'
named entity 'electrophysiology'
named entity 'oncology'
named entity 'oncology'
named entity 'left ventricular'
named entity 'study population'
named entity 'ASCO'
named entity 'Florida'
named entity 'chemotherapy treatment'
named entity 'clinical presentation'
named entity 'follow-up'
named entity 'LVEF'
named entity 'cancer treatment'
named entity 'cardiologist'
named entity 'national Registry'
named entity 'cardiovascular'
named entity 'CMR'
named entity 'LVEF'
named entity 'oncologists'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software